Tag Archives: Biologics by McKesson

Specialty Pharmacy News Roundup: January 2024

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends.

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

Takeda Selects Specialty Pharmacy Partners for ADZYNMA and FRUZAQLA

Takeda Pharmaceuticals Selects Specialty Pharmacy Partners for new FDA-approved drugs ADZYNMA and FRUZAQLA

Specialty Pharmacy News Roundup: March 2023

AMI’s Specialty Pharmacy Database continually monitors and tracks all limited and exclusive pharmacy distribution agreements

Specialty Pharmacy Limited Distribution Drug Agreements at Year-End 2022

The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities

Biologics by McKesson Selected to Provide VONJO and PYRUKYND

Biologics by McKesson continues to solidify its leadership position a provider for limited and exclusive drugs in the specialty pharmacy market

Biologics Selected by Agios Pharmaceuticals as Exclusive Distributor of PYRUKYND®

PYRUKYND prescriptions are processed exclusively through Biologics by McKesson to give patients a seamless experience

Biologics by McKesson Starting the New Year With Momentum

Biologics by McKesson, selected as a specialty pharmacy distributor for three specialty drugs recently, is starting the new year with momentum